Glatter: In practice, many patients labeled non-responders to GLP-1 therapy are experiencing incomplete dosing, early discontinuation because of gastrointestinal side effects, insufficient treatment duration, or competing metabolic drivers such as severe insulin resistance, sleep disruption, sarcopenia, or medication-associated weight gain
Next up: Im even experimenting with much lower doses than what we have in our current program, because I want to see the effects of that. BUT IS IT SAFE LONG-TERM
Introduction S-Acetyl-L-Glutathione vs L-Glutathione represents the core raw material differentiation in functional nutrition
Do you provide dosing or administration guidance
These can cause fatigue, weakness, hair loss, and other symptoms if not addressed through supplements and annual blood work